Discounted Cash Flow (DCF) Analysis Levered
genOway Société anonyme (ALGEN.PA)
4.27 €
+0.03 (+0.71%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Revenue | 10.80 | 9.46 | 11.02 | 14.02 | 17.05 | 19.31 | 21.86 | 24.76 | 28.03 | 31.74 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue (%) | ||||||||||
Operating Cash Flow | - | - | - | - | - | - | - | - | - | - |
Operating Cash Flow (%) | ||||||||||
Capital Expenditure | - | - | - | - | - | - | - | - | - | - |
Capital Expenditure (%) | ||||||||||
Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Weighted Average Cost Of Capital
Share price | $ 4.27 |
---|---|
Beta | 0.438 |
Diluted Shares Outstanding | - |
Cost of Debt | |
Tax Rate | -23.32 |
After-tax Cost of Debt | 4.33% |
Risk-Free Rate | |
Market Risk Premium | |
Cost of Equity | 6.395 |
Total Debt | 9.05 |
Total Equity | - |
Total Capital | 9.05 |
Debt Weighting | 100.00 |
Equity Weighting | 0.00 |
Wacc |
Build Up Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Revenue | 10.80 | 9.46 | 11.02 | 14.02 | 17.05 | 19.31 | 21.86 | 24.76 | 28.03 | 31.74 |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - | - | - | - | - |
Capital Expenditure | - | - | - | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
WACC | ||||||||||
PV LFCF | - | - | - | - | - | |||||
SUM PV LFCF | - |
Terminal Value
Growth in perpetuity method: | |
---|---|
Long-term growth rate | |
WACC (%) | - |
Free cash flow (t + 1) | - |
Terminal Value | - |
Present Value of Terminal Value | - |
Intrinsic Value
Enterprise Value | - |
---|---|
Net Debt | 4.17 |
Equity Value | - |
Shares Outstanding | - |
Equity Value Per Share | - |